NDC 37662-1037

Lycopus Virginicus

Lycopus Virginicus

Lycopus Virginicus is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Lycopus Virginicus.

Product ID37662-1037_e46d7b97-594d-3492-e053-2995a90acd6d
NDC37662-1037
Product TypeHuman Otc Drug
Proprietary NameLycopus Virginicus
Generic NameLycopus Virginicus
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2022-07-22
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHahnemann Laboratories, INC.
Substance NameLYCOPUS VIRGINICUS
Active Ingredient Strength6 [hp_C]/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 37662-1037-1

200 PELLET in 1 VIAL, GLASS (37662-1037-1)
Marketing Start Date2022-07-22
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lycopus Virginicus" or generic name "Lycopus Virginicus"

NDCBrand NameGeneric Name
0220-3189Lycopus virginicusLYCOPUS VIRGINICUS
0220-3194Lycopus virginicusLYCOPUS VIRGINICUS
15631-0279LYCOPUS VIRGINICUSLYCOPUS VIRGINICUS
15631-0628LYCOPUS VIRGINICUSLYCOPUS VIRGINICUS
37662-1037Lycopus VirginicusLycopus Virginicus
37662-1038Lycopus VirginicusLycopus Virginicus
37662-1039Lycopus VirginicusLycopus Virginicus
37662-1040Lycopus VirginicusLycopus Virginicus
37662-1041Lycopus VirginicusLycopus Virginicus
37662-1042Lycopus VirginicusLycopus Virginicus
37662-1043Lycopus VirginicusLycopus Virginicus
37662-1044Lycopus VirginicusLycopus Virginicus
68428-486Lycopus virginicusLYCOPUS VIRGINICUS
71919-430Lycopus virginicusLYCOPUS VIRGINICUS
64117-258COUGH HEADACHELYCOPUS VIRGINICUS

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.